GE Surges After Agreeing to $21.4 Billion Sale of BioPharma Unit
A monitor displays signage for General Electric Co. (GE) on the floor of the New York Stock Exchange (NYSE) in New York, U.S. (Photographer: Michael Nagle/Bloomberg)

GE Surges After Agreeing to $21.4 Billion Sale of BioPharma Unit

Bookmark
(Bloomberg) -- When Larry Culp took command of flailing General Electric Co. late last year, his mandate was simple: be more aggressive.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.